Decoy Therapeutics Inc. (DCOY)

Decoy Therapeutics Inc. (DCOY) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.8M; returns 1 day -5.8%, 1 week -17.1%, 1 year -97.9%.

Decoy Therapeutics Inc. (DCOY), formerly Salarius Pharmaceuticals, is a preclinical-stage biotechnology company that leverages its proprietary IMP3ACT™ platform to engineer next-generation peptide-conjugate therapeutics.

Groups DCOY belongs to

• Biotechnology
• Recent Reverse Splits
• Recent IPOs
• Preclinical Development
• Clinical Stage Biotech
• Life Sciences
• Antivirals
• Infectious Diseases
• Artificial Intelligence
• Machine Learning
• Oncology

DCOY financial model: income statement, cash flow and balance sheet